Comparative antimutagenic and anticancer activity of three fractions of black tea polyphenols thearubigins

Udayan Bhattacharya1, Sibabrata Mukhopadhyay, Ashok K Giri

  • 1Molecular and Human Genetics Division, Indian Institute of Chemical Biology, Kolkata, India.

Nutrition and Cancer
|September 17, 2011
PubMed

Insights

Black tea polyphenols, thearubigins (TR), were fractionated to assess their health benefits. The TR-2 fraction demonstrated significant antimutagenic and anticancer effects without harming normal cells, suggesting its therapeutic potential.

Area of Science:

  • Food Science
  • Biochemistry
  • Pharmacology

Background:

  • Black tea polyphenols, including theaflavins (TF) and thearubigins (TR), are known for their potential health benefits.
  • Thearubigins (TR) represent a complex mixture of polyphenols with largely uncharacterized biological activities.

Purpose of the Study:

  • To fractionate thearubigins (TR) from black tea.
  • To evaluate the antimutagenic and anticancer properties of isolated TR fractions.
  • To identify the most active TR fraction and investigate its mechanism of action.

Main Methods:

  • Chromatographic separation was used to isolate three fractions (TR-1, TR-2, TR-3) from thearubigins (TR).
  • Antimutagenic activity was assessed using the Ames assay on four Salmonella strains.
  • Anticancer activity was evaluated on human leukemic U937 cells and normal peripheral blood mononuclear cells.
  • Apoptosis induction was studied using flow cytometry and confocal microscopy.

Main Results:

  • All three TR fractions (TR-1, TR-2, TR-3) exhibited significant antimutagenic and anticancer activities.
  • None of the fractions showed significant toxicity to normal human cells at concentrations up to 100 μg/ml.
  • The TR-2 fraction was identified as the most potent among the tested fractions.
  • Apoptosis induction was suggested as a key mechanism underlying the observed anticancer effects.

Conclusions:

  • Fractionation of thearubigins (TR) yields components with distinct biological activities.
  • The TR-2 fraction possesses notable antimutagenic and anticancer properties with a favorable safety profile.
  • This study provides the first evidence for the specific activities of TR fractions, highlighting TR-2 as a promising therapeutic agent.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...